TW213901B - - Google Patents

Download PDF

Info

Publication number
TW213901B
TW213901B TW081110044A TW81110044A TW213901B TW 213901 B TW213901 B TW 213901B TW 081110044 A TW081110044 A TW 081110044A TW 81110044 A TW81110044 A TW 81110044A TW 213901 B TW213901 B TW 213901B
Authority
TW
Taiwan
Prior art keywords
phenyl
gas
page
butyl
cns
Prior art date
Application number
TW081110044A
Other languages
English (en)
Chinese (zh)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of TW213901B publication Critical patent/TW213901B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW081110044A 1992-01-27 1992-12-15 TW213901B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US82567792A 1992-01-27 1992-01-27

Publications (1)

Publication Number Publication Date
TW213901B true TW213901B (de) 1993-10-01

Family

ID=25244657

Family Applications (1)

Application Number Title Priority Date Filing Date
TW081110044A TW213901B (de) 1992-01-27 1992-12-15

Country Status (19)

Country Link
EP (1) EP0625145A1 (de)
JP (1) JPH07503465A (de)
KR (1) KR950700257A (de)
CN (1) CN1074903A (de)
AU (1) AU3276193A (de)
BR (1) BR9207071A (de)
CA (1) CA2117367A1 (de)
CZ (1) CZ391092A3 (de)
FI (1) FI943513A0 (de)
HU (1) HUT70496A (de)
IL (1) IL104472A0 (de)
MX (1) MX9300409A (de)
NO (1) NO942775L (de)
NZ (1) NZ245759A (de)
RU (1) RU94038063A (de)
TW (1) TW213901B (de)
WO (1) WO1993015059A1 (de)
YU (1) YU4393A (de)
ZA (1) ZA93582B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2097688A1 (es) * 1993-07-14 1997-04-01 Pfizer Hexahidroazepinonas y tetrahidrobenzazepinonas sustituidas.
AU6686694A (en) * 1993-07-26 1995-02-20 Pfizer Inc. Tetrahydro-1h-benzazepinones and hexahydroazepinones as selective cholecystokinin-b receptor antagonists
AU681924B2 (en) * 1993-11-22 1997-09-11 Merck & Co., Inc. 3-acylaminobenzazepines
US5453424A (en) * 1993-11-22 1995-09-26 Merck & Co., Inc. Furanodiazepines
CA2200336C (en) * 1994-10-04 2001-12-11 Pfizer Limited Processes and intermediates for preparing 3-amino-benzo(b)azepinones
ATE210447T1 (de) * 1994-10-14 2001-12-15 Glaxo Wellcome Spa Verwendung von cck-b rezeptor antagonisten zur behandlung von schlafstörungen
DE10153348A1 (de) 2001-10-29 2003-05-08 Gruenenthal Gmbh Substituierte Benzo(b)azepin-2-on-Verbindungen
MX2007016064A (es) * 2005-06-16 2008-03-10 Novartis Ag Composiciones y metodos para inhibicion viral.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0166357A3 (de) * 1984-06-26 1988-10-26 Merck & Co. Inc. Kondensierte Benzo-Laktame und deren pharmazeutische Zusammensetzungen
US4767756A (en) * 1987-07-17 1988-08-30 E. R. Squibb & Sons, Inc. 3-substituted benzazepines
EP0322779A3 (de) * 1987-12-29 1991-05-08 Yoshitomi Pharmaceutical Industries, Ltd. Benzolaktam-Verbindungen und deren pharmazeutische Verwendungen
US5206234A (en) * 1990-10-22 1993-04-27 Merck & Co., Inc. Benzolactam analogs as antagonists of cck

Also Published As

Publication number Publication date
CA2117367A1 (en) 1993-08-05
WO1993015059A1 (en) 1993-08-05
NZ245759A (en) 1997-06-24
BR9207071A (pt) 1995-12-05
EP0625145A1 (de) 1994-11-23
HU9402195D0 (en) 1994-09-28
KR950700257A (ko) 1995-01-16
MX9300409A (es) 1993-07-01
ZA93582B (en) 1994-07-27
AU3276193A (en) 1993-09-01
CZ391092A3 (en) 1994-01-19
JPH07503465A (ja) 1995-04-13
FI943513A7 (fi) 1994-07-26
IL104472A0 (en) 1993-05-13
FI943513L (fi) 1994-07-26
FI943513A0 (fi) 1994-07-26
HUT70496A (en) 1995-10-30
CN1074903A (zh) 1993-08-04
NO942775D0 (no) 1994-07-26
YU4393A (sr) 1996-01-09
RU94038063A (ru) 1996-05-27
NO942775L (no) 1994-09-20

Similar Documents

Publication Publication Date Title
US7553861B2 (en) Dipeptidyl peptidase-IV inhibitors
TW202432B (de)
JP3357660B2 (ja) 置換ヘテロ環化合物
JPH07504908A (ja) ベンゾジアゼピン誘導体，該誘導体を含有する組成物及び治療におけるその使用
KR101945139B1 (ko) 선택적 bace1 억제제
CZ283950B6 (cs) 1,5-Benzodiazepinové deriváty a jejich použití v medicíně
PL172069B1 (pl) Sposób wytwarzania nowych pochodnych podstawionej 3-aminochinuklidyny PL PL PL PL PL
JPH09503231A (ja) 新規のフェニルアルキルアミノアルコールカルバメートとその製造方法
TW213901B (de)
JPH06502620A (ja) ベンゾジアゼピン誘導体
TW438777B (en) Compounds useful as NK1 and/or NK2 anagonists and the pharmaceutical composition and preparation process thereof
US6828324B2 (en) Branched adamantyl and noradamantyl aryl-and aralkylpiperazines with serotonin 5-HT1A activity
JP2001504454A (ja) ベンゾジアゼピン誘導体
TW209870B (de)
JPH0348695A (ja) ペプチド誘導体
KR20140134904A (ko) 칼슘이온 채널 조절제로서 유효한 6-피라졸일아미도-3-치환된 아자바이사이클로[3.1.0]헥산 유도체
WO1997016425A1 (en) Novel inhibitors of peptide binding to mhc class ii proteins
IL101514A (en) Benzodiazepinone derivatives and cholecystokinin antagonist pharmaceutical compositions containing them
TWI288747B (en) Calcium salts of a 1,5-benzodiazepine derivative, a process for preparing the same, and drugs containing the same as the active ingredient
MX2011010658A (es) Inhibidor de la recaptacion de serotonina y norepinefrina.
JP6594403B2 (ja) ピリジル−トリアザビシクル
US20080306044A1 (en) Spirobenzoazepanes as vasopressin antagonists
US7342007B2 (en) Lactams and uses thereof
AU688316B2 (en) 1,5 benzodiazepine derivatives having CCK and/or gastrin antagonistic activity
CN117480161A (zh) 作为σ配体的新型2,3-二氢-1H-吡咯并[3,2-b]吡啶衍生物